Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study

NCT: NCT05409976 · ACTIVE_NOT_RECRUITING

NCT IDNCT05409976
StatusACTIVE_NOT_RECRUITING
Start Date2022-10-25
Completion2030-05-09
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

This study is a prospective, multicenter, non-randomized, single-arm study to evaluate the performance, safety, and efficacy of the GORE® VIABAHN® FORTEGRA Venous Stent (formerly known as GORE® VIAFORT Vascular Stent) for treatment of symptomatic inferior vena cava obstruction with or without combined iliofemoral obstruction in adult patients.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑